Progress in diagnosis and treatment of small cell lung cancer with integrated traditional Chinese and Western medicine

Lung cancer is one of the most common major diseases that seriously threaten human health,lung cancer includes small cell lung cancer(SCLC)and non-small cell lung cancer(NSCLC).Although patients with SCLC account for about 20%of the total number of patients with lung cancer,the mortality rate is much higher than that of patients with NSCLC.Integrated traditional Chinese and Western medicine has obvious advantages in the treatment of patients with SCLC.According to the relevant literature reports on the treatment of SCLC in recent years,this article will summarize the research progress of integrated traditional Chinese and western medicine in the treatmentof SCLC from the aspects of traditional Chinese medicine(TCM)combined with surgery,chemotherapy,radiotherapy,and molecular targeted therapy.

Efficacy evaluation of high-frequency ultrasound in the treatment of diabetic peripheral neuropathy with α-lipoic acid combined with traditional Chinese medicine package treatment

Objective:To use high-frequency ultrasound to evaluate the efficacy ofα-lipoic acid combined with traditional Chinese medicine in the treatment of diabetic peripheral neuropathy(DPN),so as to provide a basis for clinical medication and evaluation of therapeutic effect.Methods:From December 2018 to December 2019,110 patients with DPN who met the inclusion and exclusion criteria were divided into observation group and control group according to different treatment plans.The control group was treated withα-lipoic acid,and the observation group was treated withα-lipoic acid combined with traditional Chinese medicine encapsulation treatment,and used high-frequency ultrasound,nerve conduction velocity and serological examination to comprehensively evaluate the effectiveness of the two treatment methods.Results:The mean amplitude of glycemic excursions(MAGE)value of the observation group and the control group after treatment was significantly lower than before treatment(P<0.05);After treatment,the SCV of the ulnar nerve,median nerve,and common peroneal nerve in the two groups was significantly faster than before treatment(P<0.05).Similar to SCV,the MCV of the three nerves measured after treatment in the two groups was significantly faster than before treatment(P<0.05).Compared between the groups after treatment,the three kinds of nerve SCV and MCV in the observation group were significantly faster than those in the control group(P<0.05).The cross-sectional area(CSA)value of the ulnar nerve,median nerve and common peroneal nerve in the observation group after treatment was significantly lower than before treatment(P<0.05).Compared with the control group after treatment,the three nerves CSA in the observation group was significantly lower than that in the control group(P<0.05).Abnormal ultrasound performance:The proportion of abnormal ultrasound performances of the ulnar nerve,median nerve,and common peroneal nerve in the observation group after treatment was significantly lower than before treatment(P<0.05).The composition ratio of internal echo reduction and ambiguity in the observation group after three nerve treatments was significantly lower than that in the control group after treatment(P<0.05).In the correlation analysis,the three kinds of nerve CSA before and after treatment were negatively correlated with SCV and amplitude(P<0.05),and positively correlated with latency(P<0.05).Conclusion:The combination ofα-lipoic acid and Chinese medicine encapsulation technology has a good effect on the treatment and repair of DPN nerve damage,and can be routinely applied in clinical treatment.High-frequency ultrasound can intuitively observe changes in peripheral nerves and can be used to evaluate the prognosis of DPN.

A Study on the Correlation Between Cerebral Small Vascular Disease and Constitution Types of Traditional Chinese Medicine

Objective:To study the correlation between cerebral small vascular disease and constitution types of Traditional Chinese Medicine(TCM).Methods:The severity of lacunar infarction and leukoaraiosis were graded in 230 patients with cerebral small vascular disease,and they were divided into TCM constitution types.The survey of TCM constitution types was carried out by using standardized TCM constitution scale,and order multivariate Logistic regression was used to analyze the correlation between TCM constitution types with severity of lacunar infarction and leukoaraiosis.Results:Yang-deficiency(阳虚)constitution,blood-stasis constitution and phlegm-dampness constitution were the most common TCM constitution types in patients with lacunar infarction,accounting for 33.7%,12.5%,11.5%respectively.Yang-deficiency constitution,blood-stasis constitution and Yin-deficiency(阴虚)constitution were the most common TCM constitution types in patients with leukoaraiosis,accounting for 28.8%,18.5%,13.7%respectively.There were significant differences in lacunar infarction of Yang-deficiency constitution and blood stasis constitution(P<0.05),and there were significant differences in leukoaraiosis of phlegmdampness constitution and blood-stasis constitution(P<0.05).Single factor analysis showed that the main risk factors of lacunar infarction were age,smoking,alcohol consumption,Yang-deficiency constitution and blood-stasis constitution,and the main risk factors of leukoaraiosis were age,smoking,hypertensive disease,phlegm-dampness constitution and blood-stasis constitution.The ordered multivariate Logistic regression analysis found that the severity of lacunar infarction was closely related to age,and the severity of leukoplosis was closely related to age,smoking and hypertension disease.Conclusion:TCM constitution types of lacunar infarction in patients with small cerebral vascular disease is mainly Yang-deficiency constitution and blood-stasis constitution,and the risk factors include age,smoking,alcohol consumption,Yang-deficiency constitution and blood-stasis constitution.Age is closely related with lacunar infarction.TCM constitution types with leukoaraiosis are mainly phlegm-dampness constitution and blood-stasis constitution,and the risk factors are age,smoking,hypertension disease,phlegm-dampness constitution and blood-stasis constitution.Age,smoking and hypertension disease are closely related with leukoaraiosis.

Protective effects of Ligustrazine,Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis

BACKGROUND:Severe acute pancreatitis (SAP) is characterized by fatal pathogenic conditions and a high mortality.It is important to study SAP complicated with multiple organ injury.In this study we compared the protective effects of three traditional Chinese medicines (Ligustrazine,Kakonein and Panax Notoginsenoside) on the small intestine and immune organs (thymus,spleen and lymph nodes) of rats with SAP and explored their mechanism of action.METHODS:One hundred forty-four rats with SAP were randomly divided into model control,Ligustrazine-treated,Kakonein-treated,and Panax Notoginsenoside-treated groups (n=36 per group).Another 36 normal rats comprised the sham-operated group.According to the different time points after operation,the experimental rats in each group were subdivided into 3-,6-and 12-hour subgroups (n=12).At various time points after operation,the mortality rate of rats and pathological changes in the small intestine and immune organs were recorded and the serum amylase levels were measured.RESULTS:Compared to the model control groups,the mortality rates in all treated groups declined and the pathological changes in the small intestine and immune tissues were relieved to different degrees.The serum amylase levels in the three treated groups were significantly lower than those in the model control group at 12 hours.The pathological severity scores for the small intestinal mucosa,thymus and spleen (at 3 and 12 hours) in the Ligustrazine-treated group,for the thymus (at 3 and 12 hours) and spleen (at 3 and 6 hours) in the Kakonein-treated group,and for the thymus (at 3 hours)and spleen (at 3 hours) in the Panax Notoginsenoside-treated group were significantly lower than those in the model control group.The pathological severity scores of the small intestinal mucosa (at 6 and 12 hours) and thymus (at 6 hours) in the Ligustrazine-treated group were significantly lower than those in the Kakonein-and Panax Notoginsenoside-treated groups.CONCLUSIONS:All the three traditional Chinese drugs significantly alleviated the pathological changes in the small intestine and immune organs of SAP rats.Ligustrazine was the most effective one among them.

Effect of TCM Combined with Chemotherapy on Immune Function and Quality of Life of Patients with Non-small Cell Lung Cancer inStage Ⅲ-Ⅳ

Objective: To observe and compare the effect of traditional Chinese medicine (TCM) combined with chemotherapy (CT) on immune function and quality of life (QOL)of patients with non-small cell lung cancer (NSCLC) in stage Ⅲ-Ⅳ. Methods: One hundred cases with stage Ⅲ-Ⅳ NSCLC were randomly divided into two groups. The treated group (n=50) received CT combined with TCM, and the control group received CT alone. The percentage of T lymphocyte subset in peripheral blood and the change of natural killer (NK) cell count were observed after treatment. The QOL and tolerance of CT were also compared between the two groups after treatment. Results: In the treated group, CD3 cell count, CD4 cell count, CD4/ CDg ratio and NK cell activity were higher than those in control group, while CD8 cell count in the treated group was lower than that in the control group (P<0.05), and QOL and tolerance of CT in the treated group were also better (P<0.05). Conclusion: TCM combined with CT could raise the patients' ability in tolerating CT in stage Ⅲ-ⅣNSCLC.

自拟健脾除积方联合信迪利单抗及化疗对晚期非小细胞肺癌患者的影响

目的:探讨自拟健脾除积方联合信迪利单抗及化疗对晚期非小细胞肺癌患者疾病控制率、中医症候积分及不良反应的影响。方法:选取2020年10月—2022年10月在我院就诊的102例晚期非小细胞肺癌患者,随机分为观察组和对照组,每组各51例,对照组在吉西他滨+顺铂化疗的基础上给予信迪利单抗,观察组在对照组基础上联合自拟健脾除积方治疗。比较两组患者临床疗效、治疗前后中医症候积分、肿瘤标志物水平及不良反应。结果:观察组有效率和疾病控制率明显高于对照组(P<0.05);观察组和对照组治疗后中医症候积分均显著低于治疗前;治疗后,观察组中医症候积分显著低于对照组(P<0.05)。两组治疗后血清铁蛋白(SF)、鳞状细胞癌抗原(SCCA)及癌胚抗原(CEA)水平均显著低于同组治疗前,观察组SF、SCCA、CEA水平均显著低于对照组。观察组白细胞计数减少、恶心、呕吐症状总发生率显著低于对照组(P<0.05)。结论:自拟健脾除积方联合信迪利单抗对晚期非小细胞肺癌患者治疗效果较好,可改善患者中医症候,具有较高的安全性。

中国传统文化在中成药包装视觉设计里的应用研究

目的基于深厚的中国传统文化,探索更能体现传统文化特质和赢得用户认可的中成药包装视觉设计路径。方法探究现有中成药包装在融入中国传统文化元素时存在的视觉设计问题,分析中国传统文化在中成药包装视觉设计里的可用元素,在此基础上探讨中国传统文化融入中成药包装视觉设计的应用与应用原则,并辅之以案例进一步说明。结论如果遵循文章提出的应用原则,在传统文化理念指导下将传统图案、色彩、文字、艺术等具有代表性的中国传统文化元素融入中成药包装设计,能够帮助中成药包装充分展现产品自身特质,满足用户个性需求,赢得目标用户的文化认同与情感认同,提高中成药市场竞争力,为中成药产业发展注入新的动力,同时传承和发扬中国传统文化,彰显文化自信。

小针刀联合桂枝加葛根汤治疗肩关节周围炎临床观察

目的 观察小针刀联合桂枝加葛根汤治疗肩关节周围炎(以下简称肩周炎)的临床疗效。方法 将136例肩周炎患者按照随机数字表法分为2组,对照组68例予小针刀治疗,治疗组68例在对照组治疗基础上予桂枝加葛根汤口服治疗,2组疗程均为3个月。比较2组治疗前后疼痛视觉模拟评分(VAS)、美国肩肘外科协会评分(ASES)评分及肩关节活动度,统计2组疗效,随访1年记录肩周炎复发情况。结果 治疗组总有效率97.06%(66/68),对照组总有效率88.24%(60/68),治疗组临床疗效优于对照组(P<0.05)。2组治疗后疼痛VAS均较本组治疗前降低(P<0.05),且治疗组治疗后低于对照组(P<0.05)。2组治疗后ASES疼痛和功能评分均较本组治疗前升高(P<0.05),且治疗组治疗后均高于对照组(P<0.05)。2组治疗后肩关节的各方向活动度均较本组治疗前升高(P<0.05),且治疗组治疗后均高于对照组(P<0.05)。随访1年,治疗组复发率2.94%(2/68),对照组复发率13.23%(9/68),治疗组复发率低于对照组(P<0.05)。结论 小针刀联合桂枝加葛根汤治疗肩周炎疗效肯定,显著优于单用小针刀治疗,能缓解肩周疼痛,改善临床症状,复发率较低。

中医药文化在“一带一路”新兴国家传播的实证分析(2013—2023)——基于甘姆森诠释包裹理论

“一带一路”倡议提出十年来(2013-2023),作为促进民心相通的重要纽带和载体,中医药文化在共建“一带一路”国家广泛传播。以俄罗斯、印度、南非三个既是金砖国家、又是在“一带一路”沿线的全球南方新兴国家为案例,以甘姆森诠释包裹为理论框架、以这三个国家十年间中医药文化报道为样本进行基于内容分析的实证研究。研究发现,印度对社会背景和政府归因更聚焦、俄罗斯对中医药评估和后果与影响较为关注、南非重点强调生态背景和中医药归因;三国媒体中医药文化报道装置主要采用描述装置和论据装置,隐喻和短语较少;历时看,屠呦呦获诺奖(2015年)引发印度对本国医学发展的省思,激发俄罗斯对中华传统医学更大兴趣,新冠肺炎疫情防控期间关于中医药文化的讨论更为广泛多元,舆论出现两极分化;三国媒体中医药文化报道的框架装置和推理装置间存在相关性。

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer:protocol for a randomized double-blind controlled trial

BACKGROUND： Traditional Chinese medicine （TCM） is considered an important complementary therapy with beneficial effects for cancer patients. Elderly patients with non-small-cell lung cancer （NSCLC） are a complex patient group with increasing co-morbidity and shrinking physiological reserve, and may derive substantial benefit from the supportive aspects of TCM Researchers from Shanghai Longhua Hospital found that qi and yin deficiency is a common syndrome in patients with stage III or IV lung cancer. This project was designed to study the combination of single-agent chemotherapy with TCM methods of benefiting qi and yin in elderly patients with advanced NSCLC. METHODS AND DESIGN： This is a double-blind controlled, multi-center, and prospective study with randomly selected participants from elderly NSCLC patients in China. Seventy-six patients who meet the inclusion criteria will be allocated into two groups, which will receive treatments of 3-week single-agent chemotherapy with TCM or placebo for four cycles Progression-free survival （PFS） is the primary end point, and the secondary end points are overall survival, objective response rate, time-to-progression, and quality of life （EORTC QLQ-LC43, and TCM syndrome score） Meanwhile, other end points such as toxicity, side effects and safety of the treatments will be assessed. DISCUSSION： Results from this study may provide evidence on the effectiveness, and parameters for the usage of single-agent chemotherapy combined with or without TCM on PFS of elderly patients with NSCLC.

中药联合抗肿瘤血管生成药物治疗非小细胞肺癌的研究进展

非小细胞肺癌(NSCLC)是肺癌最为常见的一种病理类型,一半以上的患者确诊时即为进展期肺癌,患者生存期较短。抗肿瘤血管生成药物是目前治疗非小细胞肺癌的重要靶向药物,其临床疗效已获得临床认可,但仍存在耐药性及毒副作用不可耐受的局限性,而中药辨证论治及减毒增效的优点,可减轻药物的不良反应,并提高临床疗效,已成为中西医结合治疗非小细胞肺癌的重要方向。本文主要通过检索2010年1月—2023年6月中国知网、万方、维普及PubMed等数据库中的相关文献,总结近年来不同中药联合各类抗肿瘤血管生成药物治疗NSCLC的相关研究,试从不同角度探讨治疗NSCLC的新思路。

扶正方药治疗三线及以上晚期非小细胞肺癌临床疗效及对血清可溶性免疫检查点表达的影响

目的观察扶正方药治疗三线及以上晚期非小细胞肺癌(NSCLC)患者的疗效及对血清可溶性免疫检查点表达的影响。方法根据治疗情况将211例三线及以上晚期NSCLC患者分为暴露组(106例)、非暴露组(105例),非暴露组给予标准西医治疗方案,暴露组在标准西医治疗方案的基础上加用中医扶正方药。观察无进展生存期(PFS),绘制Kaplan-Meier生存曲线,对临床因素及预后指标进行Cox多因素分析;治疗4个周期后计算疾病控制率,比较生活质量量表[癌症患者生活质量核心问卷量表(QLQ-C30)、肺癌特异性量表(QLQ-LC13)]评分、血清可溶性免疫检查点[包括可溶性CD137(sCD137)、可溶性程序性细胞死亡配体1(sPD-L1)、可溶性程序性细胞死亡配体2(sPD-L2)、可溶性程序性死亡分子-1(sPD-1)、可溶性淋巴细胞激活基因-3蛋白(sLAG-3)、可溶性半乳糖凝集素-9(sGal-9)等]表达水平的变化情况。结果①暴露组脱落2例、非暴露组脱落1例,最终完成试验者208例,暴露组、非暴露组各104例。②暴露组、非暴露组的中位PFS分别为7.5个月、6.3个月,暴露组PFS长于非暴露组(χ^(2)=4.656,P<0.05);与非暴露组相比,暴露组PFS缩短的风险降低了22.8%。③暴露组、非暴露组疾病控制率分别为85.6%、79.8%;两组疾病控制率比较,差异无统计学意义(P>0.05)。④治疗前后组内比较,暴露组QLQ-C30量表中躯体功能、情绪功能、认知功能和总健康状况、疲倦、疼痛、气促、失眠、食欲、便秘、腹泻评分差异有统计学意义(P<0.05),QLQ-LC13量表中气促、咳嗽、口腔溃疡、其他部位痛评分降低(P<0.05);非暴露组QLQ-C30量表中躯体功能、社会功能、疼痛、气促、便秘、腹泻评分差异有统计学意义(P<0.05),QLQ-LC13量表中气促、咳嗽评分降低(P<0.05),其他部位痛评分升高(P<0.05)。组间治疗后比较,QLQ-C30量表中躯体功能、总健康状况、疲倦、疼痛、气促、食欲、便秘评分差异有统计学意义(P<0.05),QLQ-LC13量表中气促、咳嗽、口腔溃疡及其他部位痛评分差异有统计学意义(P<0.05)。⑤治疗前后组内比较,暴露组血清sPD-L1、sPD-L2水平降低,sPD-1、sGal-9水平升高(P<0.05);组间治疗后比较,sCD137、sPD-L1、sPD-L2、sLAG-3水平差异有统计学意义(P<0.05)。结论与单纯使用西医治疗相比,加用扶正方药治疗三线及以上晚期NSCLC患者具有延长PFS、改善生活质量、调节免疫微环境等作用。

中医药干预早期非小细胞肺癌的临床效果研究

目的:分析早期非小细胞肺癌(NSCLC)患者根治术后无瘤生存期的影响因素,观察中医药干预对于早期NSCLC患者的影响。方法:采用单臂、单中心数据回顾性研究,分析415例接受中医药干预的早期NSCLC患者的临床资料,运用Kaplan-Meier法对可能影响早期NSCLC预后的因素进行单因素分析,并将经显著性检验后有意义的可疑影响因素纳入Cox回归分析,建立Cox风险比例模型。结果:415例早期NSCLC患者的1年、2年、3年、5年、10年无瘤生存率为96.1%、87.5%、84.0%、76.5%、67.4%。2)单因素分析显示,性别、年龄、吸烟史、手术方式、病理类型、临床分期、中医辨证分型、中医药物及非药物治疗疗程、中医干预空白期、中医综合治疗持续时间为预后相关影响因素(P<0.05)。Cox回归分析显示,性别、临床分期、中医辨证分型、中成药疗程、中医综合治疗持续时间是影响患者预后的独立危险因素。结论:中医药干预可以提高早期NSCLC患者的无瘤生存率,改善预后。2)早期NSCLC患者中,女性、年轻、不吸烟、行电视胸腔镜辅助手术、肺腺癌(贴壁型为主)、临床分期早、气阴两虚及肺脾气虚型患者预后佳。术后中医药干预空白期短且长期中医综合辨证治疗可以提高患者无病生存率。

中医药治疗晚期非小细胞肺癌的研究进展

非小细胞肺癌(NSCLC)是一种常见的肺部恶性肿瘤,已成为全球癌症死亡的主要原因之一,晚期NSCLC患者的预后普遍较差,该病已给全球公共卫生带来严重负担。晚期NSCLC的治疗一直是临床面临的难题,由于肿瘤细胞的扩散和转移,局部晚期可能会在新辅助治疗后行手术治疗,但效果往往不尽人意,且副作用较大。近年来,中医药在治疗晚期NSCLC方面取得了显著的进展,受到了广泛关注。该文对近几年中医药治疗晚期NSCLC的相关研究进行归纳总结,探讨了中医药治疗的作用机制,为临床实践提供参考。

2020版《中华人民共和国药典》中小毒中药的毒性特点与外用分析

目的 通过对2020版《中华人民共和国药典》中小毒中药的毒性特点进行分析,探明小毒中药的关键药效活性成分,阐述小毒中药的毒副作用与不良反应,排除临床用药的隐患;并且基于外用的方式对小毒中药进行临床应用分析,以期为临床提供数据参考。方法 参照2020版《中华人民共和国药典》进行小毒中药筛选,在中国知网中进行检索,依循纳入与排除标准使用Excel进行分析。结果 小毒中药外用在治疗骨关节疾病、皮肤病、肛肠疾病、疼痛、妇科疾病、腺体炎症、呼吸系统疾病、神经系统疾病、胸腹水肿、失眠、外伤等领域均有较好的临床表现。小毒中药普遍具有肝毒性,久服易造成肝损伤,其毒性物质基础多为生物碱类、皂苷类以及萜类;动物类中药以多肽为主要成分;小毒中药中毒表现多为头晕、呕吐及胃肠道反应,鲜有危及生命的临床案例报道。小毒中药可做糊、膏、穴位贴剂和直接敷于患处,其常用的赋形剂为醇溶剂、醋、蜂蜜等。结论 小毒中药临床应用广泛,但又因其普遍具有肝毒性,通过外用手段可以使得药物的吸收分布更加均匀,降低肝脏的代谢负担,其较口服更为安全,通过对小毒中药的外用方式进行分析,探明其外用规律,补充了小毒中药的外用剂量范围,为临床用药提供数据参考。

融合Lasso的近似马尔科夫毯特征选择方法

在特征选择问题中,近似马尔科夫毯常用于判断冗余特征,但所得到的冗余特征并不完全相同,因此,在直接使用近似马尔科夫毯删除冗余特征时,存在可能导致信息丢失的情况,影响模型精度。为此,提出一种用于中药代谢组学高维小样本数据的融合Lasso的近似马尔科夫毯特征选择方法。方法分为两个阶段,第一阶段,通过最大信息系数对特征的相关度分析过滤无关特征;第二阶段,采用近似马尔科夫毯构建相似特征组,使用Lasso评估相似特征组中特征影响力,迭代去除冗余特征。通过实验对比表明,该算法可以在一定程度上减少有用信息丢失,去除无关特征和冗余特征,提高模型精度和稳定性。

疏肝健脾法对非小细胞肺癌患者化疗期间肿瘤标志物的影响

目的:探讨疏肝健脾法对非小细胞肺癌(NSCLC)患者化疗期间肿瘤标志物水平的影响。方法:选取NSCLC患者100例,采用随机数字表法分为观察组、对照组,各50例。对照组患者给予常规化疗方案,观察组患者在对照组基础上联合疏肝健脾法。比较两组患者临床疗效,同时评估中医证候积分、血清肿瘤标志物[癌胚抗原(CEA)、癌抗原125(CA125)]、免疫功能指标[抗原分化簇4受体(CD4^(+))、抗原分化簇8受体(CD8^(+))、CD4^(+)/CD8^(+)]。最后比较两组患者不良反应发生情况。结果:观察组患者疾病控制率96.00%高于对照组84.00%,差异有统计学意义(P<0.05)。观察组患者治疗后食少纳呆、体倦乏力、神疲懒言、腹痛绵绵、舌质淡、脉细弱积分低于对照组,差异有统计学意义(均P<0.05)。观察组患者治疗后血清CEA、CA125指标低于对照组,差异有统计学意义(P<0.05)。观察组患者治疗后CD4^(+)、CD4^(+)/CD8^(+)高于对照组,CD8^(+)指标低于对照组,差异有统计学意义(均P<0.05)。观察组、对照组不良反应总发生率分别为16.00%、28.00%,组间比较差异无统计学意义(P>0.05)。结论:疏肝健脾法用于NSCLC患者化疗期间不仅能有效改善患者临床症状、体征,改善患者血清肿瘤标志物、免疫功能,安全性较理想。

中药材及饮片检测中人工智能应用探讨

目前,中药材及饮片的市场需求快速增长,其质量控制与安全保障更显迫切;传统的中药材及饮片检测手段存在主观经验依赖、检测精度有限、无法全面量化复杂成分等问题,难以满足中药材及饮片在准确分类与鉴别、精准成分测量等方面的需求,而人工智能技术的快速发展与广泛应用为中药材及饮片检测提供了新的解决方案。本文总结了中药材及饮片检测的现有方法及应用现状,系统梳理了人工智能技术在药材分类、真伪鉴别、产地溯源、有害成分测量、有效成分测量、药效测量等方面的典型应用,深入分析了当前面临的数据收集与标准化,检测数据共享机制,快速、无损、低成本检测技术需求,检测数据准确性,多模态检测数据融合等问题。研究认为,智能化、精准化、快速化是中药材及饮片检测未来的重点发展方向,需要持续完善检测标准与数据共享体系、深化人工智能技术研究与应用、强化多模态数据融合技术应用、引入新型传感技术、加强人工智能技术应用监管,以此推动我国中药材及饮片检测高质量发展,保障中医药产业的持续健康发展。

小针刀联合补肾活血祛痛方治疗腰椎间盘突出症临床观察

目的 探讨小针刀联合补肾活血祛痛方治疗腰椎间盘突出症(LDH)的临床效果。方法 选取2016年7月—2018年4月沈阳市中医院收治的135例患者作为研究对象,将所有患者随机分为甲组(小针刀联合补肾活血祛痛方)、乙组(补肾活血祛痛方)和丙组(小针刀),观察与对比3组患者的腰痛分级、治疗前后视觉模拟量表(VAS)评分和总体效果。结果 甲组总有效率为97.78%(44/45),高于乙组的88.89%(40/45)、丙组的82.22%(37/45),差异具有统计学意义(P<0.05);甲组治疗后VAS评分下降程度明显大于乙组和丙组;甲组治疗后Denis腰痛分级明显优于乙组和丙组,差异具有统计学意义(P<0.05)。结论对LDH患者进行小针刀联合补肾活血祛痛方治疗可以有效缓解患者的疼痛程度、缩短患者的住院时间、提升患者的生活质量,同时患者腰椎功能可以得到快速恢复,值得临床应用与推广。

跗骨窦小切口入路内固定术配合中医正骨手法治疗跟骨骨折的临床疗效评价

目的:研究跗骨窦小切口入路内固定术配合中医正骨手法治疗跟骨骨折的临床疗效。方法:以回顾性分析为法,观察对象为2018年1月至2022年6月清远市中医院的80例跟骨骨折患者,依据治疗方案不同分为两组,观察组在跗骨窦小切口入路内固定术的基础上配合中医正骨手法辅助治疗,对照组实施跗骨窦小切口入路内固定术。收集两组患者的一般资料及影像学参数,并对手术时间、术中出血量、住院时长、疼痛程度、跟骨参数、足踝功能以及并发症予以分析。结果:组间对比性别、年龄等资料,差异无统计学意义(P>0.05);术中出血量、住院时间观察组明显低于对照组(P<0.05),手术时长比较,差异无统计学意义(P>0.05);随着术后时间的延长,两组患者的VAS疼痛评分均下降,以观察组降低幅度更大,差异有统计学意义(P<0.05);两组术前Gissane角、Bohler角、Pitch角、足踝评分比较,差异无统计学意义(P>0.05);较术前,两组术后Gissane角、Bohler角、Pitch角均增大,足踝评分升高,差异有统计学意义(P<0.05);两组Gissane角、Bohler角、Pitch角、足踝评分手术前后差值比较,差异有统计学意义(P<0.05);观察组术后并发症发生率2.38%,与对照组的并发症发生率5.26%比较,差异无统计学意义(χ^(2)=1.065,P>0.05)。结论:跗骨窦小切口入路内固定术配合中医正骨手法治疗跟骨骨折患者临床疗效较好,能够配合手术进程,弥补不能充分暴露的缺点,达到良好复位的目的,并能缩短住院时间,减少术中出血量、降低疼痛程度,促进足部功能与骨折端解剖结构的恢复,且安全性较高。